Xianguang Bai, Kai Yang, Shengle Tian, Longfei Zhao, Xuhang Ba, Yupeng Xia
HER2-positive breast cancer is an aggressive subtype of breast cancer with poor prognosis. With the continuous development of targeted therapies, the treatment strategies and prognosis for this disease have
...